Major Drivers Propelling the Growth oh theVeterinary Intravenous (IV) Solutions Market Forward: Rising Prevalence Of Animal Diseases Fuels Market Growth
Discover trends, market shifts, and competitive outlooks for the veterinary intravenous (iv) solutions industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research
#What Is the Estimated Market Size of the Veterinary Intravenous (IV) Solutions Market In 2029?#_x000D_
The market for veterinary intravenous (IV) solutions has seen robust growth in the past few years. The industry is projected to increase from a value of $1.5 billion in 2024 to $1.62 billion in 2025, with a compound annual growth rate (CAGR) of 8.1%. The historical growth is due to several factors, which include an uptick in animal clinics, a surge in dehydration incidents, an increase in livestock farming, a growth in the number of pet animals, and advancements in veterinary diagnostics._x000D_
_x000D_
The market size for veterinary intravenous (IV) solutions is predicted to witness substantial growth in the coming years, expanding to a value of $2.19 billion in 2029 with a compound annual growth rate (CAGR) of 7.8%. Factors contributing to this anticipated growth within the forecast period include an increase in pet insurance adoption, heightened expenditure on animal healthcare, improving awareness around animal healthcare, a rise in animal disease instances and an expansion in pet insurance coverage. Key trends anticipated in the forecast period encompass advancements in technology, a variety of product formulations, the integration of telemedicine, cutting-edge veterinary intravenous (IV) delivery systems and the emergence of intelligent veterinary intravenous (IV) systems._x000D_
_x000D_
#Download a free sample to assess the report’s scope and structure:#_x000D_
https://www.thebusinessresearchcompany.com/sample.aspx?id=20686&type=smp_x000D_
_x000D_
#Which Major Market Drivers Are Expected to Boost the Growth Potential of the Veterinary Intravenous (IV) Solutions Market?#_x000D_
The surge in the occurrence of numerous diseases among animals is anticipated to spur the expansion of the veterinary intravenous (IV) solutions market in the coming years. These diseases, comprising ailments such as anthrax, canine distemper, heartworm disease, and more, adversely affect the health and functioning of animals. A rise in such diseases is propelled by factors like intensive farming methods, intrusion of wildlife, and resistance to antibiotics. Veterinary IV solutions are vital in treating animals suffering from dehydration-causing ailments like gastroenteritis or severe infections, by providing ideal hydration and enhancing overall health outcomes. For example, AVMA Publications, a publishing division of the American Veterinary Medical Association based in the US, reported that around 345 domestic animals were diagnosed with rabies in 2022, a 10.9% increase from the 311 cases accounted for in 2021. Thus, the increasing number of animal diseases is contributing to the growth of the veterinary intravenous (IV) solutions market. An uptick in the expenditure on animal health products is projected to fuel the growth of the veterinary intravenous (IV) solutions market in the near future. Animal health product encompasses items like medications, supplements and treatments used to preserve or enhance the wellness of animals. The escalation in expenditure on animal health products arises from factors such as the growth of pet ownership, increasing knowledge of animal health, advancements in veterinary care and the requirement for enhanced disease prevention and treatment options. Veterinary IV solutions contribute to the increase in expenditure on animal health products by satisfying immediate medical needs and progressing veterinary care. As an indication, the Republic of Estonia Agency of Medicines revealed in March 2024 that in 2023, the market for veterinary medicinal products increased by 6.9% to reach $20.54 million (18.6 million euros), up from USD 19.21 million (17.40 million euros) in 2022. Therefore, the growing expenditure on animal health products is influencing the growth of the veterinary intravenous (IV) solutions market._x000D_
_x000D_
#Which Key Market Segments Comprise the Veterinary Intravenous (IV) Solutions Market and Drive Its Revenue Growth?#_x000D_
The veterinary intravenous (IV) solutions market covered in this report is segmented –_x000D_
_x000D_
1) By Product: Isotonic Crystalloids, Dextrose Solutions, Synthetic Colloids, Natural Colloids, Parenteral Nutrition_x000D_
2) By Animal Type: Companion Animals, Production Animals_x000D_
3) By End-User: Veterinary Hospitals And Clinics, Research Institutes, Other End-Users_x000D_
_x000D_
Subsegments:_x000D_
1) Isotonic Crystalloids: Normal Saline (0.9% NaCl), Lactated Ringer’s Solution, Dextrose in Water (D5W), Ringer’s Solution, Balanced Electrolyte Solutions_x000D_
2) Dextrose Solutions: Dextrose 5% in Water (D5W), Dextrose 10% in Water (D10W), Dextrose 20% in Water (D20W), Dextrose 50% in Water (D50W)_x000D_
3) Synthetic Colloids: Hydroxyethyl Starch (HES), Dextran, Gelatins_x000D_
4) Natural Colloids: Albumin, Fresh Frozen Plasma (FFP), Blood Products_x000D_
5) Parenteral Nutrition: Total Parenteral Nutrition (TPN) Solutions, Partial Parenteral Nutrition Solutions, Lipid Emulsions, Amino Acid Solutions_x000D_
_x000D_
#Request customized data on this market:#_x000D_
https://www.thebusinessresearchcompany.com/customise?id=20686&type=smp_x000D_
_x000D_
#Which Areas Are Leading Regions in the Veterinary Intravenous (IV) Solutions Market Expansion Across the Globe?#_x000D_
North America was the largest region in the veterinary intravenous (IV) solutions market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary intravenous (IV) solutions market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#What Are the Most Significant Market Trends in the Veterinary Intravenous (IV) Solutions Market?#_x000D_
Leading organizations in the veterinary intravenous (IV) solutions market are concentrating on the innovation of state-of-the-art products like fluoroquinolones, aiming to enhance their efficacy and safety aspects. Fluoroquinolones, being potent antibiotics, are utilized in both human and animal healthcare to address a range of bacterial infections with caution to limit resistance and side effects occurrence. For instance, in April 2024, Elanco, an American pharmaceutical enterprise, publicized the approval of Pradalex, a pradofloxacin injection solution granted by the US Food and Drug Administration (FDA), a healthcare organization in the United States. This permits swine treatment for swine respiratory disease (SRD) linked to pathogens like bordetella bronchiseptica, Glaesserella (Haemophilus) parasuis, Pasteurella multocida, streptococcus suis, and mycoplasma hyopneumoniae. Recognized as a critical antimicrobial, Pradalex is a 3rd generation fluoroquinolone. The medication’s label underlines its application only when other therapeutic options beyond fluoroquinolones have been explored._x000D_
_x000D_
#View the full report here:#_x000D_
_x000D_
#How Is the Veterinary Intravenous (IV) Solutions Market Conceptually Defined?#_x000D_
Veterinary intravenous (IV) solutions are sterile fluids administered directly into the bloodstream of animals through a vein, typically via an IV catheter. These solutions are used in veterinary medicine to treat dehydration and electrolyte imbalances, deliver medications, or provide nutrients. Veterinary intravenous (IV) solutions are essential for maintaining or restoring the proper fluid and electrolyte balance in animals, especially in illness, surgery, or trauma cases._x000D_
_x000D_
#Purchase the full report and get a swift delivery:#_x000D_
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20686_x000D_
_x000D_
#About The Business Research Company:#_x000D_
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_
_x000D_
#Get in touch with us:#_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas +1 3156230293_x000D_
Asia +44 2071930708_x000D_
Europe +44 2071930708_x000D_
Email us at info@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
